Healthcare Press

Johnson & Johnson quarterly profit jumps 32per cent

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Johnson & Johnson on Wednesday posted a 32per cent rise in fourth-quarter profit, boosted by demand for its cancer drugs Darzalex and Imbruvica.

The company's net earnings rose to US$4.01 billion, or US$1.50 per share, in the quarter, from US$3.04 billion, or US$1.12 per share, a year earlier.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines